Compound Summary
Compound Name: | L-Allylglycine |
Compound CID: | 167529 |
Synonyms: | L-Allylglycine 16338-48-0 (S)-2-aminopent-4-enoic acid (2S)-2-aminopent-4-enoic acid (S)-(-)-2-Amino-4-pentenoic acid More... |
Iupac Name: | (2S)-2-aminopent-4-enoic acid |
InChI: | InChI=1S/C5H9NO2/c1-2-3-4(6)5(7)8/h2,4H,1,3,6H2,(H,7,8)/t4-/m0/s1 |
InChIKey: | WNNNWFKQCKFSDK-BYPYZUCNSA-N |
Canonical Smiles: | C=CCC(C(=O)O)N |
Isomeric Smiles: | C=CC[C@@H](C(=O)O)N |
Molecular Weight: | 115.13 |
Molecular Formula: | C5H9NO2 |
Molecular Weight: | 115.13 |
Molecular Formula: | C5H9NO2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 8 |
Complexity: | 101 |
L-Allylglycine | L-Allylglycine |
---|---|
L-Allylglycine |
16338-48-0 |
(S)-2-aminopent-4-enoic acid |
(2S)-2-aminopent-4-enoic acid |
(S)-(-)-2-Amino-4-pentenoic acid |
H-Gly(Ally)-OH |
s-allylglycine |
(S)-2-Amino-4-pentenoic acid |
4-Pentenoic acid, 2-amino-, (2S)- |
L-2-Amino-4-pentenoic acid |
L-alpha-Allyl-Gly |
(S)-ALLYLGLYCINE |
D-Allylglycine |
(2S)-2-azaniumylpent-4-enoate |
MFCD00002627 |
(S)-2-Amino-4- Pentenoic Acid |
(-)-Allylglycine |
H-Algly-OH |
3-VINYL-L-ALANINE |
(2S)-2-amino-4-pentenoic acid |
(S)-2-Amino-pent-4-enoic acid |
2-Allyl-L-glycine |
4-Pentenoic acid, 2-amino-, (S)- |
Lopac-A-7762 |
Lopac0_000141 |
SCHEMBL74086 |
GTPL5267 |
(2S)-2-aminopent-4-enoicacid |
CHEMBL1229875 |
DTXSID10936821 |
HMS3260M04 |
ACT02836 |
ZINC1696507 |
Tox21_500141 |
SBB006743 |
(S)-(?)-2-Amino-4-pentenoic acid |
AKOS006339850 |
AKOS015853990 |
AC-9624 |
AM84669 |
CCG-204236 |
CS-W013622 |
GS-6220 |
LP00141 |
SDCCGSBI-0050129.P002 |
NCGC00015091-01 |
NCGC00093631-01 |
NCGC00093631-02 |
NCGC00093631-03 |
NCGC00093631-04 |
NCGC00260826-01 |
L-|A inverted exclamation mark-Allyl-Gly |
L-Allylglycine, >=99% (TLC), powder |
AB0005354 |
EU-0100141 |
(S)-(-)-2-Amino-4-pentenoic acid, 98% |
A 7762 |
316A724 |
SR-01000075687 |
(S)-2-aminopent-4-enoic acid;3-VINYL-L-ALANINE |
J-010040 |
SR-01000075687-1 |
Q27088686 |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | -11 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -11 | 1 | 1 |